ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Geriatric Medicine

Top Geriatric Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KETANKUMAR VAIDYA MD

Geriatric Medicine

8,162

$611K

321
264 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $67

JAMES ATKINSON M.D.

Geriatric Medicine

7,965

$607K

588
526 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$76
Average prescription price

Avg: $67

RAYMOND LANZA D.O., FACP, CMD

Geriatric Medicine

7,785

$486K

352
321 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $67

JOSEPH RYAN MD, MPH

Geriatric Medicine

7,401

$396K

216
207 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $67

JESSE WASSNER MD

Geriatric Medicine

7,147

$398K

545
545 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $67

BENNETT LEIFER M.D.

Geriatric Medicine

7,088

$458K

512
499 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $67

LOURDES MCALARNEY MD

Geriatric Medicine

7,056

$429K

351
349 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $67

SUNITA RAYUDU M.D

Geriatric Medicine

6,946

$371K

239
224 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $67

SARITA RASTOGI M.D.

Geriatric Medicine

6,772

$549K

515
465 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $67

JOHN SUNDHEIM MD

Geriatric Medicine

6,696

$486K

537
516 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $67

WILLIAM POWER M.D.

Geriatric Medicine

6,646

$578K

474
446 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$87
Average prescription price

Avg: $67

ARUNIMA SARKAR MD

Geriatric Medicine

6,385

$265K

315
303 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$42
Average prescription price

Avg: $67

BHAVANA REBBA M.D.

Geriatric Medicine

6,351

$406K

206
190 are 65+

25%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

JOSHUA SCHOR M.D.

Geriatric Medicine

6,246

$282K

154
152 are 65+

21%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$45
Average prescription price

Avg: $67

ABHIJIT CHATTERJEE MD

Geriatric Medicine

6,220

$490K

322
308 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$79
Average prescription price

Avg: $67

ALICIA PROWSE MD

Geriatric Medicine

6,186

$353K

194
176 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $67

MANISHA PARULEKAR M.D.

Geriatric Medicine

6,119

$245K

325
310 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$40
Average prescription price

Avg: $67

REKHA GOHEL M.D.

Geriatric Medicine

6,055

$380K

343
316 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $67

THERESA REDLING D.O.

Geriatric Medicine

6,046

$710K

323
317 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 29%

$117
Average prescription price

Avg: $67

DIANA DECOSIMO M.D.

Geriatric Medicine

5,723

$322K

270
170 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $67

PRIYA ANGI M.D

Geriatric Medicine

5,721

$367K

222
206 are 65+

21%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

LESLIE FEIGIN

Geriatric Medicine

5,595

$462K

336
260 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $67

ELENA REGALMAN MD

Geriatric Medicine

5,271

$337K

138
108 are 65+

22%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

JOSEPH SCHULMAN DO

Geriatric Medicine

5,052

$325K

230
180 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

LAURA CHAVEZ DO

Geriatric Medicine

4,954

$323K

316
270 are 65+

22%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank